Combined Aerobic and Resistance Exercise Program in Adults: Endocrine and Metabolic Adaptations
Life · 19.08.2026 · 16 (8) · 1365
DOI: 10.3390/life16081365 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life, online erschienen am 19.08.2026. Verfasst von Leopoldo Ferrante und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Economics, Law, Cybersecurity and Sports Sciences, University of Naples Parthenope, 80035 Nola, Italy. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Physical exercise induces coordinated endocrine and metabolic adaptations that contribute to the regulation of glucose homeostasis, lipid metabolism, stress responses, and anabolic processes. However, the integrated effects of combined aerobic and resistance exercise on multiple endocrine and metabolic outcomes require further investigation. This study aimed to evaluate the effects of a 12-week combined aerobic and resistance exercise program on endocrine and metabolic parameters in normal-weight and mildly overweight adults.
Methods
A total of 60 adults were randomly allocated to an exercise group (EX, n = 30) or a control group (CON, n = 30). The EX-group completed a supervised 12-week combined exercise program consisting of three 60 min sessions per week, including aerobic exercise and multi-joint resistance training, whereas the CON-group maintained their habitual physical activity levels. Endocrine parameters, including insulin, glucagon, cortisol, growth hormone (GH), thyroid hormones, and sex-specific hormones, as well as fasting glucose, lipid profile, and homeostasis model assessment of insulin resistance (HOMA-IR), were assessed at baseline and after 12 weeks.
Results
Compared with the control condition, the exercise program was associated with favorable changes in endocrine and metabolic profiles. The EX-group showed reductions in fasting insulin, cortisol, fasting glucose, and HOMA-IR, together with increased GH levels. Favorable changes were also observed in the lipid profile, including reductions in total cholesterol, low-density lipoprotein cholesterol (LDL), and triglycerides and an increase in high-density lipoproteins cholesterol (HDL). In the male subgroup, total testosterone increased following the intervention, whereas estradiol changes in the female subgroup were more limited. Changes in insulin were associated with changes in glucose regulation and lipid parameters, while GH and cortisol changes showed additional associations with metabolic outcomes.
Conclusions
These findings support the role of structured combined exercise as a non-pharmacological strategy for promoting endocrine and metabolic health and preventing metabolic dysfunction.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Economics, Law, Cybersecurity and Sports Sciences, University of Naples Parthenope, 80035 Nola, Italy.
- Department of Biological and Environmental Sciences and Technologies, University of Salento, 73100 Lecce, Italy.
- Department of Medical, Human Movement and Well-Being Sciences, University of Naples Parthenope, Via Medina 40, 80133 Napoli, Italy.
- Department of Literary, Linguistic and Philosophical Studies, Pegaso University, 80143 Naples, Italy.
ORCID-Profile: Francesca Latino
Zitieren
APA
Ferrante, L., Latino, F., Amato, G., & Tafuri, M. G. (2026). Combined Aerobic and Resistance Exercise Program in Adults: Endocrine and Metabolic Adaptations. Life, 16(8), 1365. https://doi.org/10.3390/life16081365
Vancouver
Ferrante L, Latino F, Amato G, Tafuri MG. Combined Aerobic and Resistance Exercise Program in Adults: Endocrine and Metabolic Adaptations. Life. 2026;16(8):1365. doi:10.3390/life16081365
BibTeX
@article{Ferrante2026,
author = {Ferrante, Leopoldo and Latino, Francesca and Amato, Giulia and Tafuri, Maria Giovanna},
title = {Combined Aerobic and Resistance Exercise Program in Adults: Endocrine and Metabolic Adaptations},
journal = {Life},
year = {2026},
volume = {16},
number = {8},
pages = {1365},
doi = {10.3390/life16081365}
}
EUVIMED